SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-130478
Filing Date
2023-12-29
Accepted
2023-12-29 16:15:21
Documents
13
Period of Report
2023-12-27
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2333843d1_8k.htm   iXBRL 8-K 30120
2 EXHIBIT 99.1 tm2333843d1_ex99-1.htm EX-99.1 81870
  Complete submission text file 0001104659-23-130478.txt   305277

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pasg-20231227.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pasg-20231227_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pasg-20231227_pre.xml EX-101.PRE 22363
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2333843d1_8k_htm.xml XML 3442
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 231527845
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)